Deep generative models (DGMs) are changing the story of drug design. They have been applied for drug design in a research level in pharmaceutical companies and still a number of structure-based and ligand-based approaches for generative models are being developed. For recent examples, see 1), 2) for structure-based and 3). 4) for ligand-based ones. While...